In the October 8, 2014, Federal Register, FDA published its determination that LUPRON DEPOT (leuprolide acetate for depot suspension), an injectable vial containing 3.75 milligrams of the drug, was not withdrawn from sale for reasons of safety or effectiveness.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.